AMANDA HARRUP: Open Payments
NPI 1558972166 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 49 payments from 17 companies in 2025. Trend: 2023 $2,185 · 2024 $1,311 · 2025 $897
Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $201 |
| PFIZER INC. | 10 | $139 |
| GlaxoSmithKline, LLC. | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| ABBVIE INC. | 4 | $72 |
| Dexcom, Inc. | 3 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $59 |
| Alnylam Pharmaceuticals Inc. | 2 | $42 |
| Lilly USA, LLC | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: Ozempic, NURTEC ODT, Dexcom G6 Transmitter, TRELEGY ELLIPTA, Kerendia, Rybelsus, UBRELVY, PREVNAR 20.
Industry payments across TN — which companies pay providers there.
